GLP1R and Hyperglycemia: As a follow-up to our previous study in which GLP1 receptor agonists fully protected against olanzapine-induced hyperglycemia and markers of lipid dysregulation (Medak et al., 2020) we aimed to determine if increasing endogenous GLP1 could be protective in the same way.